Trial · NCT07890441
Pregnancy Anti-inflammatory Diet Intervention Study
NCT07890441, Not applicable, Not yet recruiting, Capital Medical University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pregnancy Anti-inflammatory Diet Intervention Study. Trials, record NCT07890441. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890441
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pregnancy Anti-inflammatory Diet Intervention Study
- NCT number
- NCT07890441
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Capital Medical University
- Conditions
- Pregnancy, Dietary Inflammatory Index (DII)
- Interventions
- Anti-inflammatory Dietary Intervention
- First posted
- 2026-10-22
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Dietary Inflammatory Index (DII) Score | At baseline, 24 and 36 weeks of gestation; 2 months postpartum | Dietary Inflammatory Index scores were calculated from participants' dietary intake data. Higher scores indicate a more pro-inflammatory diet, whereas lower scores indicate a more anti-inflammatory diet. |
| Secondary | Change in Maternal High-Sensitivity C-Reactive Protein (hs-CRP) Concentration | At baseline and 36 weeks of gestation | Maternal blood high-sensitivity C-reactive protein (hs-CRP) concentration will be measured in mg/L. hs-CRP is a pro-inflammatory cytokine involved in the regulation of inflammatory and immune responses and serves as a biomarker of maternal systemic inflammation during pregnancy. |
| Secondary | Change in Maternal Interleukin-6 (IL-6) Concentration | At baseline and 36 weeks of gestation | Maternal blood interleukin-6 (IL-6) concentration will be measured in pg/mL. IL-6 is a pro-inflammatory cytokine involved in the regulation of inflammatory and immune responses and serves as a biomarker of maternal systemic inflammation during pregnancy. |
| Secondary | Change in Maternal Tumor Necrosis Factor-alpha (TNF-α) Concentration | At baseline and 36 weeks of gestation | Maternal blood tumor necrosis factor-alpha (TNF-α) concentration will be measured in pg/mL. TNF-α is a pro-inflammatory cytokine involved in the regulation of inflammatory and immune responses and serves as a biomarker of maternal systemic inflammation during pregnancy. |
| Secondary | Change in Mediterranean Diet Adherence Screener Score | At baseline, 24 and 36 weeks of gestation; 2 months postpartum | Mediterranean Diet Adherence Screener scores range from 0 to 14. Higher scores indicate greater adherence to the Mediterranean diet. |
| Secondary | Change in Adapted Healthy Eating Index for Pregnant Women Score | At baseline, 24 and 36 weeks of gestation; 2 months postpartum | The Adapted Healthy Eating Index for Pregnant Women assesses overall diet quality during pregnancy. Higher scores indicate better diet quality. |
| Secondary | Gestational Weight Gain | At baseline, 24 and 36 weeks of gestation | Maternal gestational weight gain was calculated in kilograms from measured body weight during pregnancy. Higher values indicate greater weight gain. |
| Secondary | Edinburgh Postnatal Depression Scale Score | At 2 months postpartum | Postpartum depressive symptoms were assessed using the 10-item Edinburgh Postnatal Depression Scale. Total scores range from 0 to 30, with higher scores indicating more severe depressive symptoms. |
| Secondary | Infant Body Weight | At birth and at 2 months of age | Infant body weight was measured in grams. |
| Secondary | Infant Length | At birth and at 2 months of age | Infant recumbent length was measured in centimeters. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890441
GET https://conductscience.org/api/trials/v1/NCT07890441/registered